The University of Chicago Medicine Comprehensive Cancer Center, Chicago
UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
UChicago Medicine Orland Park, Orland Park

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT05868226

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Illinois Cancer Specialists, Arlington Heights
Illinois CancerCare - Bloomington, Bloomington
Illinois Cancer Specialists, Chicago
a 10 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Chicago, Zion

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07277413

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Illinois CancerCare - Bloomington, Bloomington
University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center), Chicago
University of Illinois Hospital and Health Sciences System, Chicago
a 10 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07222566

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Cancer Care Specialists of Illinois, Decatur
Decatur Memorial Hospital, Decatur
Hope and Healing Clinical Research LLC, Hinsdale
a 2 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06989437

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Chicago

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

City of Hope Chicago, Zion

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07007559

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

University of Chicago, Chicago

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

University of Illinois at Chicago, Chicago
University of Chicago Medical Center, Chicago
Endeavor Health, Evanston
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07218380

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Northwest Oncology & Hematology, Elk Grove Village

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07028489

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

City of Hope, Chicago, Chicago
Northwestern Memorial Hospital, Chicago
University of Illinois at Chicago, Chicago
a 3 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Illinois Cancer Specialists, Arlington Heights
Northwestern Memorial Hospital, Chicago
Rush University Medical Center, Chicago
a 2 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213804

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

Midwestern Regional Medical Center dba City of Hope Chicago, Zion

Prebieha náborFáza 1

Vek 18 až 99 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07403721

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Memorial Hospital, Shiloh
Siteman Cancer Center - Shiloh, Shiloh
City Of Hope - Chicago, Zion

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07227415

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

The University of Chicago Medical Center - Duchossois Center for Advanced Medicine, Chicago

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT06566079

CREO - Microwave Ablation Feasibility Study

Rush University Medical Center, Chicago

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07817147

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

Northwestern University ( Site 0101), Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07030712

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Research Site, Evanston

Prebieha náborFáza 3

Vek 18 až 130 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07647328

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Illinois at Chicago, Chicago
University of Chicago Hospital, Chicago
Springfield Clinic Main Campus, Springfield

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

University of Chicago, New Lenox

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06561685

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Northwestern University, Chicago

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT06311214

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Northwestern University, Chicago
Southern Illinois University-Simmons, Springfield
Carle Foundation Cancer Institute-Urbana, Urbana

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06072612

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Northwestern University, Chicago

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT07594626

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Northwestern University, Evanston

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

The University of Chicago Medical Center (UCMC), Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT05614739

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Research Site, Chicago

Prebieha náborFáza 2

Vek 18 až 130 · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT06792695

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

University of Chicago Comprehensive Cancer Center, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT05687110

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Hope and Healing Cancer Services, Hinsdale

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Chicago
Research Site, Peoria
Research Site, Urbana

Prebieha náborFáza 3

Vek 18 a viac · Ženy · Aktualizované 29. 7. 2026 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

The University of Chicago Medicine, Chicago

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 14. 7. 2026 · NCT05533697

A Study of PYX-201 in Advanced Solid Tumors

University of Chicago Medicine, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 6. 2026 · NCT05720117

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Northwest Oncology & Hematology, Barrington
Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst
Edward Cancer Center, Naperville
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 6. 2026 · NCT06216301

A Study of LY4175408 in Participants With Advanced Cancer

The University of Chicago Medical Center (UCMC), Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT07046923

REMASTer: REcurrent Brain Metastases After SRS Trial

University of Chicago, Chicago

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 6. 2026 · NCT05124912

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Northwestern University, Chicago

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 6. 2026 · NCT05208047

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Context Investigational Site, Chicago

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT06756035

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.